Surprisingly, molecular studies focusing on the expression of the IL‐1 family on SS skin highlighted the often‐inhomogeneous expression of IL‐1β in different samples analysed, suggesting that hyperactivation of the IL‐1 pathway might actually occur only in a subgroup of SS patients. This evidence concerns the gene IL1B and synovial sarcoma.